Cegla, P.; Hofheinz, F.; Cholewiński, W.; Czepczyński, R.; Kubiak, A.; van den Hoff, J.; Boś-Liedke, A.; Roszak, A.; Burchardt, E.
Prognostic Value of Pretherapeutic Primary Tumor MTV from [18F]FDG PET in Radically Treated Cervical Cancer Patients. Metabolites 2021, 11, 809.
https://doi.org/10.3390/metabo11120809
AMA Style
Cegla P, Hofheinz F, Cholewiński W, Czepczyński R, Kubiak A, van den Hoff J, Boś-Liedke A, Roszak A, Burchardt E.
Prognostic Value of Pretherapeutic Primary Tumor MTV from [18F]FDG PET in Radically Treated Cervical Cancer Patients. Metabolites. 2021; 11(12):809.
https://doi.org/10.3390/metabo11120809
Chicago/Turabian Style
Cegla, Paulina, Frank Hofheinz, Witold Cholewiński, Rafał Czepczyński, Anna Kubiak, Jörg van den Hoff, Agnieszka Boś-Liedke, Andrzej Roszak, and Ewa Burchardt.
2021. "Prognostic Value of Pretherapeutic Primary Tumor MTV from [18F]FDG PET in Radically Treated Cervical Cancer Patients" Metabolites 11, no. 12: 809.
https://doi.org/10.3390/metabo11120809
APA Style
Cegla, P., Hofheinz, F., Cholewiński, W., Czepczyński, R., Kubiak, A., van den Hoff, J., Boś-Liedke, A., Roszak, A., & Burchardt, E.
(2021). Prognostic Value of Pretherapeutic Primary Tumor MTV from [18F]FDG PET in Radically Treated Cervical Cancer Patients. Metabolites, 11(12), 809.
https://doi.org/10.3390/metabo11120809